• Citer

The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.

par Hamilton, Andrew;Piccart-Gebhart, Martine
Référence Annals of oncology, 10, 4, page (377-384)
Publication Publié, 1999-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	The third-generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer.
Auteur:	Hamilton, Andrew; Piccart-Gebhart, Martine
Informations sur la publication:	Annals of oncology, 10, 4, page (377-384)
Statut de publication:	Publié, 1999-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Antineoplastic Agents, Hormonal -- therapeutic use
	Aromatase Inhibitors
	Belgium
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- mortality
	Breast Neoplasms -- pathology
	Clinical Trials as Topic -- statistics & numerical data
	Disease Progression
	Female
	Humans
	Middle Aged
	Neoplasm Metastasis
	Nitriles -- therapeutic use
	Postmenopause
	Severity of Illness Index
	Survival Rate
	Tamoxifen -- therapeutic use
	Treatment Outcome
	Triazoles -- therapeutic use
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Review
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1023/A:1008368300827
	info:scp/0032907539
	info:pmid/10370778